Edition:
United States

Galectin Therapeutics Reports Q2 Loss Per Share Of $0.11


Tuesday, 14 Aug 2018 08:00am EDT 

Aug 14 (Reuters) - Galectin Therapeutics Inc ::GALECTIN THERAPEUTICS REPORTS 2018 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE $0.11.AS OF JUNE 30, 2018, CO HAD $10.5 MILLION OF NON-RESTRICTED CASH AND CASH EQUIVALENTS.BELIEVES IT HAS SUFFICIENT CASH ON HAND TO FUND PLANNED OPERATIONS THROUGH AT LEAST JUNE 30, 2019. 

Company Quote

5.06
0.32 +6.75%
16 Nov 2018